Enrolled August 29, 2024 Passed IN Senate January 22, 2024 Passed IN Assembly August 27, 2024 Amended IN Senate January 04, 2024 Amended IN Senate January 03, 2024 Amended IN Senate April 24, 2023 Amended IN Senate April 17, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Senate Bill No. 607Introduced by Senator PortantinoFebruary 15, 2023 An act to amend Section 11158.1 of the Health and Safety Code, relating to controlled substances.LEGISLATIVE COUNSEL'S DIGESTSB 607, Portantino. Controlled substances.Existing law requires a prescriber, with certain exceptions, before directly dispensing or issuing for a minor the first prescription for a controlled substance containing an opioid in a single course of treatment, to discuss specified information with the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment.This bill would extend that requirement for the prescriber by applying it to any patient, not only a minor, under those circumstances.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 11158.1 of the Health and Safety Code is amended to read:11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:(1) The risks of addiction and overdose associated with the use of opioids.(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.(4) Any other information required by law.(b) This section does not apply in any of the following circumstances:(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.
Enrolled August 29, 2024 Passed IN Senate January 22, 2024 Passed IN Assembly August 27, 2024 Amended IN Senate January 04, 2024 Amended IN Senate January 03, 2024 Amended IN Senate April 24, 2023 Amended IN Senate April 17, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Senate Bill No. 607Introduced by Senator PortantinoFebruary 15, 2023 An act to amend Section 11158.1 of the Health and Safety Code, relating to controlled substances.LEGISLATIVE COUNSEL'S DIGESTSB 607, Portantino. Controlled substances.Existing law requires a prescriber, with certain exceptions, before directly dispensing or issuing for a minor the first prescription for a controlled substance containing an opioid in a single course of treatment, to discuss specified information with the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment.This bill would extend that requirement for the prescriber by applying it to any patient, not only a minor, under those circumstances.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
Enrolled August 29, 2024 Passed IN Senate January 22, 2024 Passed IN Assembly August 27, 2024 Amended IN Senate January 04, 2024 Amended IN Senate January 03, 2024 Amended IN Senate April 24, 2023 Amended IN Senate April 17, 2023
Enrolled August 29, 2024
Passed IN Senate January 22, 2024
Passed IN Assembly August 27, 2024
Amended IN Senate January 04, 2024
Amended IN Senate January 03, 2024
Amended IN Senate April 24, 2023
Amended IN Senate April 17, 2023
CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION
Senate Bill
No. 607
Introduced by Senator PortantinoFebruary 15, 2023
Introduced by Senator Portantino
February 15, 2023
An act to amend Section 11158.1 of the Health and Safety Code, relating to controlled substances.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
SB 607, Portantino. Controlled substances.
Existing law requires a prescriber, with certain exceptions, before directly dispensing or issuing for a minor the first prescription for a controlled substance containing an opioid in a single course of treatment, to discuss specified information with the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment.This bill would extend that requirement for the prescriber by applying it to any patient, not only a minor, under those circumstances.
Existing law requires a prescriber, with certain exceptions, before directly dispensing or issuing for a minor the first prescription for a controlled substance containing an opioid in a single course of treatment, to discuss specified information with the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment.
This bill would extend that requirement for the prescriber by applying it to any patient, not only a minor, under those circumstances.
## Digest Key
## Bill Text
The people of the State of California do enact as follows:SECTION 1. Section 11158.1 of the Health and Safety Code is amended to read:11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:(1) The risks of addiction and overdose associated with the use of opioids.(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.(4) Any other information required by law.(b) This section does not apply in any of the following circumstances:(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.
The people of the State of California do enact as follows:
## The people of the State of California do enact as follows:
SECTION 1. Section 11158.1 of the Health and Safety Code is amended to read:11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:(1) The risks of addiction and overdose associated with the use of opioids.(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.(4) Any other information required by law.(b) This section does not apply in any of the following circumstances:(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.
SECTION 1. Section 11158.1 of the Health and Safety Code is amended to read:
### SECTION 1.
11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:(1) The risks of addiction and overdose associated with the use of opioids.(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.(4) Any other information required by law.(b) This section does not apply in any of the following circumstances:(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.
11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:(1) The risks of addiction and overdose associated with the use of opioids.(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.(4) Any other information required by law.(b) This section does not apply in any of the following circumstances:(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.
11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:(1) The risks of addiction and overdose associated with the use of opioids.(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.(4) Any other information required by law.(b) This section does not apply in any of the following circumstances:(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.
11158.1. (a) Except when a patient is being treated as set forth in Sections 11159, 11159.2, and 11167.5, and Article 2 (commencing with Section 11215) of Chapter 5, pertaining to the treatment of persons with substance use disorder, except when a patient is currently receiving hospice care, a prescriber shall discuss all of the following information with the patient, or if the patient is a minor, the minor, the minors parent or guardian, or another adult authorized to consent to the minors medical treatment, before directly dispensing or issuing to a patient the first prescription in a single course of treatment for a controlled substance containing an opioid:
(1) The risks of addiction and overdose associated with the use of opioids.
(2) The increased risk of addiction to an opioid for an individual who is suffering from both mental and substance abuse disorders.
(3) The danger of taking an opioid with a benzodiazepine, alcohol, or another central nervous system depressant.
(4) Any other information required by law.
(b) This section does not apply in any of the following circumstances:
(1) If the patients treatment includes emergency services and care as defined in Section 1317.1.
(2) If the patients treatment is associated with, or incidental to, an emergency surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.
(3) If, in the prescribers professional judgment, fulfilling the requirements of subdivision (a) would be detrimental to the patients health or safety, or in violation of the patients legal rights regarding confidentiality.
(c) Notwithstanding any other law, including Section 11374, failure to comply with this section shall not constitute a criminal offense.